Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.
Laniado-Laborín
Rafael
R
D000995:Antitubercular Agents / Q000627:therapeutic use*; D003140:Communicable Disease Control / Q000592:standards*; D014943:Global Health; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D015995:Prevalence; D012293:Rifampin / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000453:epidemiology
D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin